Safety and clinical activity of PD-L1 blockade in patients with aggressive recurrent respiratory papillomatosis.

J Immunother Cancer · 2019 · PMC6500000 · PMID 31053174

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

failed to reach statistical significanceno p-value reported

There was a trend toward greater likelihood of experiencing a partial response to avelumab in patients with RRP associated with HPV 6 compared to HPV 11, although this failed to reach statistical significance in this small cohort (Additional file 1 : Figure S1).

also in 6,035 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.